Danny Jones

No, they paid $400 less than they're showing on the balance sheet because they got the rebate of the $300.

Does this make sense so far?

Okay.

At the end of the year, a company like mine who employs over 600 people has to sit down with the insurance carrier where you settle up.

And I told you earlier, 90% of Americans are covered through insurance through their employer.

So at the end of the year, it's the employer that covers the holding cost of all those medicines.

And that is how UnitedHealthcare has gone from what it was 20 years ago to doing $368 billion in revenue.

$368 billion in revenue.

Roughly, estimates are anywhere from 20 to 30% of their revenue came from pharmacy benefit managers.

It is a cost center for them.

It is a major cashflow revenue source for the insurance companies.

And now you go, they have all these levers to pull.

so one lever is we're going to pay you less to see patients now you have less time with a patient what that means is you can reach for the tools as fast as you can right now you can't really do the deep dive so now the average american went from being on one or two drugs to being on four drugs all four of those drugs have rebates all of those rebates go to your middlemen all those rebates go to your cost center that is now a profit center that now adds up to your quarterly earnings

And now I'm a new CEO at United or Cigna or Aetna, and I'm looking at it going, we've got to perpetuate the lie.

And we can't stop it because I'm not going to be the CEO that dies on this hill.

And I don't know if you saw, they've been doing Senate hearings about this and congressional hearings.

And they literally ask everyone in these executives from these pharmacy benefit managers to raise their hands if they also own pharmacies.

And they're all raising their hands.

Raise your hands if you also have gone out and acquired primary care practices.

They all raise their hands.